ArticleInternational journal of oncology2023

α‑hederin overcomes hypoxia‑mediated drug resistance in colorectal cancer by inhibiting the AKT/Bcl2 pathway.

Jinbao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.